Literature DB >> 21604947

Radical retropubic prostatectomy: a review of outcomes and side-effects.

Jonas Hugosson1, Johan Stranne, Sigrid V Carlsson.   

Abstract

BACKGROUND: Radical prostatectomy (RP) is worldwide probably the most common procedure to treat localized prostate cancer (PC). Due to a more widespread use of Prostate-Specific Antigen (PSA) testing, patients operated today are often younger and have organ confined disease justifying a more preservative surgery. At the same time, surgical technique has improved resulting in lower risk of permanent side-effects. This paper aims to give an overview of results from modern surgery regarding cancer control and side-effects. A brief overview of the history is given.
MATERIAL AND METHODS: A literature research identified recently published papers focusing on outcome and side-effects after RP.
RESULTS: One large randomized study (SPCG-4) compared RP and watchful waiting (WW). The study showed that RP was superior to WW in preventing local progression (RR = 0.36), distant metastasis (RR = 0.65) and death from PC (RR = 0.65). Observational studies also show a better outcome for men treated with RP compared to WW. Peri-operative mortality after RP is low in most material around 0.1%. The risk of stricture of the vesico-urethral anastomosis has decreased with improved technique from historically 10-20% to a low incidence of around 2-9% today. Also the risk of incontinence has declined with improved technique. However, while the rates of severe incontinence is usually very low, as many as 30% still report light incontinence after long-term follow-up. Erectile dysfunction (ED) is still a frequent side-effect after RP. This risk is dependent on age, pre-operative sexual function, surgical technique and other risk factors for ED such as smoking, diabetes, etc. In selected subgroups the risk of ED is low. Inguinal hernia is a more recently described complication after open retropubic RP with a postoperative incidence of 15-20% within three years of surgery.
CONCLUSION: RP is an effective method to achieve cancer control in selected patients. With modern technique it is a safe procedure with a low risk of permanent side-effects except for ED.

Entities:  

Mesh:

Year:  2011        PMID: 21604947     DOI: 10.3109/0284186X.2010.535848

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  12 in total

1.  Radical prostatectomy versus deferred treatment for localised prostate cancer.

Authors:  Robin Wm Vernooij; Michelle Lancee; Anne Cleves; Philipp Dahm; Chris H Bangma; Katja Kh Aben
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

2.  Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.

Authors:  Yong Yang; Hong Yang; Miao Xu; Haibin Zhang; Mingtao Sun; Peng Mu; Tongbao Dong; Shanmei Du; Kui Liu
Journal:  Hum Cell       Date:  2018-04-20       Impact factor: 4.174

3.  Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy.

Authors:  Michael J Oneal; Miguel A Trujillo; Julia Davydova; Samantha McDonough; Masato Yamamoto; John C Morris
Journal:  Hum Gene Ther       Date:  2012-08-22       Impact factor: 5.695

4.  Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment.

Authors:  Anne Holck Storås; Martin G Sanda; Montse Ferrer; Jon Håvard Loge; Alv A Dahl; Eivind A S Steinsvik; Ferran Guedea; Milada Cvancarova; Sophie D Fosså
Journal:  Clin Genitourin Cancer       Date:  2014-01-03       Impact factor: 2.872

5.  Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer.

Authors:  Hui-Jie Jia; Yang Li; Jin-Guo Wang; Ling Zhang; Hai-Tao Zhang; Xue-Jian Zhao; Masaaki Kuwahara
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

6.  Inguinal hernia repair with the mesh plug method is safe after radical retropubic prostatectomy.

Authors:  Hiroaki Niitsu; Junya Taomoto; Koji Mita; Masanori Yoshimitsu; Yoichi Sugiyama; Naoki Hirabayashi; Wataru Takiyama
Journal:  Surg Today       Date:  2013-11-20       Impact factor: 2.549

7.  MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.

Authors:  Leah C Rider; Lindsey U Rodrigues; Lauren K Jillson; Lina Romero; Anis Karimpour-Fard; Cera Nieto; Claire Gillette; Kathleen Torkko; Etienne Danis; Elizabeth E Smith; Rosalie Nolley; Donna M Peehl; M Scott Lucia; James C Costello; Scott D Cramer
Journal:  Mol Cancer Res       Date:  2021-04-12       Impact factor: 5.852

8.  Efficacy of using three-tesla magnetic resonance imaging diagnosis of capsule invasion for decision-making about neurovascular bundle preservation in robotic-assisted radical prostatectomy.

Authors:  Kazushi Tanaka; Katsumi Shigemura; Mototsugu Muramaki; Satoru Takahashi; Hideaki Miyake; Masato Fujisawa
Journal:  Korean J Urol       Date:  2013-07-15

9.  Inguinal hernia developed after radical retropubic surgery for prostate cancer.

Authors:  Choon Sik Chung; Gyu Young Jeong; Seung Han Kim; Dong Keun Lee
Journal:  J Korean Surg Soc       Date:  2013-09-30

Review 10.  TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy.

Authors:  Luís Korrodi-Gregório; Joana Vieira Silva; Luís Santos-Sousa; Maria João Freitas; Juliana Felgueiras; Margarida Fardilha
Journal:  J Cell Mol Med       Date:  2014-03-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.